Search

everythinglearnresearchcommunity

for

Search:↓

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Polymeric nanohydrogels show potential for skin drug delivery but have concerns like toxicity and regulatory hurdles.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Different cell types work together to repair skin, and targeting them may improve healing and reduce scarring.

Teledermatology could improve skin care access, but its success depends on technology, quality strategies, and payment policies; also, vitamin B12 might help treat a specific hair loss condition.

CGF therapy may effectively treat psoriasis by reducing inflammation.

The article concludes that a thorough diagnosis and treatment plan, including medications, non-invasive methods, or surgery, is important for managing hair loss, with a combination of minoxidil and finasteride being particularly effective.

Acne keloidalis nuchae is a chronic skin condition more common in African men, causing itchy or painful bumps and can lead to permanent hair loss if not treated early.

Teriflunomide often causes mild to moderate hair thinning and loss in MS patients, which usually improves with or without treatment.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Activating autophagy in dogs with certain diseases improves their skin and hair.

Some chemicals and drugs can cause hair loss, which usually grows back after stopping the treatment.

Dr. Jia-You Fang is a highly experienced researcher in drug delivery and related fields, with numerous publications and international collaborations.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Exosome therapy shows promise for treating skin conditions and improving wound healing.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Erosive pustular dermatosis is a rare skin disease that's hard to treat and affects the scalp or legs.

Plum-blossom needling with conventional treatments improves hair regrowth in alopecia areata.

The document concludes that various skin conditions have specific characteristics and treatments, and highlights the importance of vitamin D in managing these dermatological issues.

Fractional CO2 laser treatment significantly boosts drug and nanoparticle skin absorption, especially through hair follicles.

Confocal Laser Scanning Microscopy (CLSM) is a useful tool for studying how drugs interact with skin and diagnosing skin disorders, despite some limitations.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.